averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZBTB14
|
ENSG00000198081.6 | zinc finger and BTB domain containing 14 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZBTB14 | hg19_v2_chr18_-_5296138_5296194 | 0.23 | 7.9e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_+_38420623 | 67.73 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
chr16_+_56623433 | 52.82 |
ENST00000570176.1
|
MT3
|
metallothionein 3 |
chrX_+_38420783 | 50.50 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
chr4_+_158141843 | 49.84 |
ENST00000509417.1
ENST00000296526.7 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr3_-_133614597 | 49.15 |
ENST00000285208.4
ENST00000460865.3 |
RAB6B
|
RAB6B, member RAS oncogene family |
chr1_+_204797749 | 48.78 |
ENST00000367172.4
ENST00000367171.4 ENST00000367170.4 ENST00000338515.6 ENST00000339876.6 ENST00000338586.6 ENST00000539706.1 ENST00000360049.4 ENST00000367169.4 ENST00000446412.1 ENST00000403080.1 |
NFASC
|
neurofascin |
chr4_+_158141899 | 48.77 |
ENST00000264426.9
ENST00000506284.1 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr16_+_2039946 | 48.65 |
ENST00000248121.2
ENST00000568896.1 |
SYNGR3
|
synaptogyrin 3 |
chr1_+_6845384 | 48.49 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr15_+_91643442 | 47.10 |
ENST00000394232.1
|
SV2B
|
synaptic vesicle glycoprotein 2B |
chr3_-_133614421 | 45.59 |
ENST00000543906.1
|
RAB6B
|
RAB6B, member RAS oncogene family |
chr13_-_36705425 | 45.34 |
ENST00000255448.4
ENST00000360631.3 ENST00000379892.4 |
DCLK1
|
doublecortin-like kinase 1 |
chr2_+_17935119 | 43.87 |
ENST00000317402.7
|
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr16_+_222846 | 42.33 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr4_+_158141806 | 41.06 |
ENST00000393815.2
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr11_-_6440283 | 37.63 |
ENST00000299402.6
ENST00000609360.1 ENST00000389906.2 ENST00000532020.2 |
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
chr8_+_24772455 | 35.81 |
ENST00000433454.2
|
NEFM
|
neurofilament, medium polypeptide |
chr1_-_9884011 | 33.31 |
ENST00000361311.4
|
CLSTN1
|
calsyntenin 1 |
chr11_-_125366089 | 33.28 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
chr17_+_43971643 | 32.56 |
ENST00000344290.5
ENST00000262410.5 ENST00000351559.5 ENST00000340799.5 ENST00000535772.1 ENST00000347967.5 |
MAPT
|
microtubule-associated protein tau |
chr17_+_43972010 | 31.66 |
ENST00000334239.8
ENST00000446361.3 |
MAPT
|
microtubule-associated protein tau |
chr7_+_45613958 | 30.69 |
ENST00000297323.7
|
ADCY1
|
adenylate cyclase 1 (brain) |
chr16_+_226658 | 29.85 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr11_-_6440624 | 29.47 |
ENST00000311051.3
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
chr9_+_17579084 | 29.40 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
chr17_-_42277203 | 28.77 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr2_-_175869936 | 27.50 |
ENST00000409900.3
|
CHN1
|
chimerin 1 |
chr12_+_121078355 | 27.39 |
ENST00000316803.3
|
CABP1
|
calcium binding protein 1 |
chr17_+_44668035 | 26.64 |
ENST00000398238.4
ENST00000225282.8 |
NSF
|
N-ethylmaleimide-sensitive factor |
chr12_-_124457257 | 24.95 |
ENST00000545891.1
|
CCDC92
|
coiled-coil domain containing 92 |
chrX_+_11776410 | 24.79 |
ENST00000361672.2
|
MSL3
|
male-specific lethal 3 homolog (Drosophila) |
chr16_+_6533380 | 24.22 |
ENST00000552089.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr10_+_105036909 | 24.00 |
ENST00000369849.4
|
INA
|
internexin neuronal intermediate filament protein, alpha |
chr22_-_20104700 | 23.91 |
ENST00000439169.2
ENST00000445045.1 ENST00000404751.3 ENST00000252136.7 ENST00000403707.3 |
TRMT2A
|
tRNA methyltransferase 2 homolog A (S. cerevisiae) |
chr2_-_175870085 | 23.85 |
ENST00000409156.3
|
CHN1
|
chimerin 1 |
chr16_+_30710462 | 23.66 |
ENST00000262518.4
ENST00000395059.2 ENST00000344771.4 |
SRCAP
|
Snf2-related CREBBP activator protein |
chr12_-_124457371 | 22.83 |
ENST00000238156.3
ENST00000545037.1 |
CCDC92
|
coiled-coil domain containing 92 |
chr6_+_31865552 | 22.41 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
chr2_+_17935383 | 22.35 |
ENST00000524465.1
ENST00000381254.2 ENST00000532257.1 |
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr2_+_79740118 | 21.94 |
ENST00000496558.1
ENST00000451966.1 |
CTNNA2
|
catenin (cadherin-associated protein), alpha 2 |
chr11_+_71791849 | 21.82 |
ENST00000423494.2
ENST00000539587.1 ENST00000538478.1 ENST00000324866.7 ENST00000439209.1 |
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing |
chr5_-_11904152 | 20.81 |
ENST00000304623.8
ENST00000458100.2 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
chr5_-_11904100 | 20.65 |
ENST00000359640.2
|
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
chr14_-_23770683 | 20.63 |
ENST00000561437.1
ENST00000559942.1 ENST00000560913.1 ENST00000559314.1 ENST00000558058.1 |
PPP1R3E
|
protein phosphatase 1, regulatory subunit 3E |
chr19_+_18942761 | 20.28 |
ENST00000599848.1
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast) |
chr1_+_1981890 | 20.27 |
ENST00000378567.3
ENST00000468310.1 |
PRKCZ
|
protein kinase C, zeta |
chr19_+_35634146 | 20.02 |
ENST00000586063.1
ENST00000270310.2 ENST00000588265.1 |
FXYD7
|
FXYD domain containing ion transport regulator 7 |
chr19_+_35521572 | 19.75 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr15_+_75287861 | 19.68 |
ENST00000425597.3
ENST00000562327.1 ENST00000568018.1 ENST00000562212.1 ENST00000567920.1 ENST00000566872.1 ENST00000361900.6 ENST00000545456.1 |
SCAMP5
|
secretory carrier membrane protein 5 |
chr6_-_33285505 | 19.65 |
ENST00000431845.2
|
ZBTB22
|
zinc finger and BTB domain containing 22 |
chr11_+_71791693 | 19.47 |
ENST00000289488.2
ENST00000447974.1 |
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing |
chr20_+_44657845 | 19.45 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr19_-_19006890 | 19.26 |
ENST00000247005.6
|
GDF1
|
growth differentiation factor 1 |
chr19_+_35521616 | 19.14 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr20_+_17207665 | 18.83 |
ENST00000536609.1
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2 |
chr16_+_1662326 | 18.81 |
ENST00000397412.3
|
CRAMP1L
|
Crm, cramped-like (Drosophila) |
chr17_-_79139817 | 18.60 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
chr9_+_131314859 | 18.28 |
ENST00000358161.5
ENST00000372731.4 ENST00000372739.3 |
SPTAN1
|
spectrin, alpha, non-erythrocytic 1 |
chr19_-_7939319 | 18.24 |
ENST00000539422.1
|
CTD-3193O13.9
|
Protein FLJ22184 |
chr9_-_115095883 | 17.93 |
ENST00000450374.1
ENST00000374255.2 ENST00000334318.6 ENST00000374257.1 |
PTBP3
|
polypyrimidine tract binding protein 3 |
chr22_-_39239987 | 17.82 |
ENST00000333039.2
|
NPTXR
|
neuronal pentraxin receptor |
chr19_-_46974741 | 17.78 |
ENST00000313683.10
ENST00000602246.1 |
PNMAL1
|
paraneoplastic Ma antigen family-like 1 |
chr1_-_20812690 | 17.69 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr1_-_223537475 | 17.64 |
ENST00000344029.6
ENST00000494793.2 ENST00000366878.4 ENST00000366877.3 |
SUSD4
|
sushi domain containing 4 |
chr7_-_44365216 | 17.48 |
ENST00000358707.3
ENST00000457475.1 ENST00000440254.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
chr19_-_19006920 | 17.43 |
ENST00000429504.2
ENST00000427170.2 |
CERS1
|
ceramide synthase 1 |
chr19_-_46974664 | 17.24 |
ENST00000438932.2
|
PNMAL1
|
paraneoplastic Ma antigen family-like 1 |
chr8_+_142402089 | 17.13 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
chr16_+_6533729 | 17.11 |
ENST00000551752.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr2_-_86564776 | 16.52 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
chr9_+_6757634 | 16.46 |
ENST00000543771.1
ENST00000401787.3 ENST00000381306.3 ENST00000381309.3 |
KDM4C
|
lysine (K)-specific demethylase 4C |
chr7_-_44365020 | 16.33 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
chr20_+_20348740 | 16.16 |
ENST00000310227.1
|
INSM1
|
insulinoma-associated 1 |
chr7_+_65338230 | 16.16 |
ENST00000360768.3
|
VKORC1L1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr22_-_45559642 | 15.78 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
chr16_-_1661988 | 15.46 |
ENST00000426508.2
|
IFT140
|
intraflagellar transport 140 homolog (Chlamydomonas) |
chr11_-_64410787 | 15.30 |
ENST00000301894.2
|
NRXN2
|
neurexin 2 |
chr15_-_71146480 | 15.29 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
chr4_-_5894777 | 15.22 |
ENST00000324989.7
|
CRMP1
|
collapsin response mediator protein 1 |
chr19_+_48281803 | 15.18 |
ENST00000601048.1
|
SEPW1
|
selenoprotein W, 1 |
chr20_+_17207636 | 15.17 |
ENST00000262545.2
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2 |
chr9_-_86571628 | 15.05 |
ENST00000376344.3
|
C9orf64
|
chromosome 9 open reading frame 64 |
chr20_-_35492048 | 15.01 |
ENST00000237536.4
|
SOGA1
|
suppressor of glucose, autophagy associated 1 |
chr4_+_41258786 | 14.83 |
ENST00000503431.1
ENST00000284440.4 ENST00000508768.1 ENST00000512788.1 |
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
chr1_+_84543734 | 14.82 |
ENST00000370689.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr19_-_11591848 | 14.80 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
chr22_+_39745930 | 14.79 |
ENST00000318801.4
ENST00000216155.7 ENST00000406293.3 ENST00000328933.5 |
SYNGR1
|
synaptogyrin 1 |
chr14_-_104313824 | 14.78 |
ENST00000553739.1
ENST00000202556.9 |
PPP1R13B
|
protein phosphatase 1, regulatory subunit 13B |
chr14_-_93651186 | 14.74 |
ENST00000556883.1
ENST00000298894.4 |
MOAP1
|
modulator of apoptosis 1 |
chr17_+_80416482 | 14.73 |
ENST00000309794.11
ENST00000345415.7 ENST00000457415.3 ENST00000584411.1 ENST00000412079.2 ENST00000577432.1 |
NARF
|
nuclear prelamin A recognition factor |
chr17_+_53343577 | 14.71 |
ENST00000573945.1
|
HLF
|
hepatic leukemia factor |
chr19_+_48281842 | 14.61 |
ENST00000509570.2
|
SEPW1
|
selenoprotein W, 1 |
chr12_-_54982300 | 14.59 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr17_-_78450398 | 14.53 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
chr5_-_88179302 | 14.53 |
ENST00000504921.2
|
MEF2C
|
myocyte enhancer factor 2C |
chr2_-_28113217 | 14.46 |
ENST00000444339.2
|
RBKS
|
ribokinase |
chr14_+_102027688 | 14.44 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
chr11_-_76155618 | 14.29 |
ENST00000530759.1
|
RP11-111M22.3
|
RP11-111M22.3 |
chr19_+_5904866 | 14.23 |
ENST00000339485.3
|
VMAC
|
vimentin-type intermediate filament associated coiled-coil protein |
chr3_+_147127142 | 14.20 |
ENST00000282928.4
|
ZIC1
|
Zic family member 1 |
chr17_+_40811283 | 14.16 |
ENST00000251412.7
|
TUBG2
|
tubulin, gamma 2 |
chr8_-_125740730 | 14.16 |
ENST00000354184.4
|
MTSS1
|
metastasis suppressor 1 |
chr11_-_76155700 | 14.15 |
ENST00000572035.1
|
RP11-111M22.3
|
RP11-111M22.3 |
chr16_+_56225248 | 14.12 |
ENST00000262493.6
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
chr7_+_98246588 | 14.10 |
ENST00000265634.3
|
NPTX2
|
neuronal pentraxin II |
chr9_-_139922631 | 14.09 |
ENST00000341511.6
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
chr8_-_144242020 | 14.03 |
ENST00000414417.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr3_+_49591881 | 13.97 |
ENST00000296452.4
|
BSN
|
bassoon presynaptic cytomatrix protein |
chr9_-_139922726 | 13.81 |
ENST00000265662.5
ENST00000371605.3 |
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
chr8_+_85095769 | 13.68 |
ENST00000518566.1
|
RALYL
|
RALY RNA binding protein-like |
chr11_+_17741111 | 13.59 |
ENST00000250003.3
|
MYOD1
|
myogenic differentiation 1 |
chr22_+_41777927 | 13.56 |
ENST00000266304.4
|
TEF
|
thyrotrophic embryonic factor |
chr6_-_143266297 | 13.36 |
ENST00000367603.2
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2 |
chr12_+_13197218 | 13.23 |
ENST00000197268.8
|
KIAA1467
|
KIAA1467 |
chr17_-_27893990 | 13.14 |
ENST00000307201.4
|
ABHD15
|
abhydrolase domain containing 15 |
chr19_+_45596398 | 13.10 |
ENST00000544069.2
|
PPP1R37
|
protein phosphatase 1, regulatory subunit 37 |
chr8_+_12809093 | 13.08 |
ENST00000528753.2
|
KIAA1456
|
KIAA1456 |
chr7_+_121513143 | 12.99 |
ENST00000393386.2
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
chr3_+_142838091 | 12.88 |
ENST00000309575.3
|
CHST2
|
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 |
chr22_-_31742218 | 12.85 |
ENST00000266269.5
ENST00000405309.3 ENST00000351933.4 |
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1 |
chr17_-_19771216 | 12.78 |
ENST00000395544.4
|
ULK2
|
unc-51 like autophagy activating kinase 2 |
chr11_-_45687128 | 12.73 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr8_-_125740514 | 12.71 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
chr12_+_123717458 | 12.60 |
ENST00000253233.1
|
C12orf65
|
chromosome 12 open reading frame 65 |
chr1_-_21948906 | 12.56 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr10_-_735553 | 12.49 |
ENST00000280886.6
ENST00000423550.1 |
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
chr9_+_71320596 | 12.45 |
ENST00000265382.3
|
PIP5K1B
|
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
chr7_-_139876812 | 12.44 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
chr20_+_32077880 | 12.37 |
ENST00000342704.6
ENST00000375279.2 |
CBFA2T2
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 2 |
chr12_-_125052010 | 12.32 |
ENST00000458234.1
|
NCOR2
|
nuclear receptor corepressor 2 |
chr11_-_134281812 | 12.28 |
ENST00000392580.1
ENST00000312527.4 |
B3GAT1
|
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
chr3_+_14989186 | 12.28 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
chr8_-_144241432 | 12.20 |
ENST00000430474.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr15_-_58357866 | 12.15 |
ENST00000537372.1
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2 |
chr12_-_48551366 | 12.12 |
ENST00000535988.1
ENST00000536953.1 ENST00000535055.1 ENST00000317697.3 ENST00000536549.1 |
ASB8
|
ankyrin repeat and SOCS box containing 8 |
chrX_-_137793826 | 12.11 |
ENST00000315930.6
|
FGF13
|
fibroblast growth factor 13 |
chr19_+_18942720 | 12.10 |
ENST00000262803.5
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast) |
chr18_-_51750948 | 12.03 |
ENST00000583046.1
ENST00000398398.2 |
MBD2
|
methyl-CpG binding domain protein 2 |
chr8_+_85095497 | 12.00 |
ENST00000522455.1
ENST00000521695.1 |
RALYL
|
RALY RNA binding protein-like |
chr16_-_75498553 | 11.98 |
ENST00000569276.1
ENST00000357613.4 ENST00000561878.1 ENST00000566980.1 ENST00000567194.1 |
TMEM170A
RP11-77K12.1
|
transmembrane protein 170A Uncharacterized protein |
chr1_-_223537401 | 11.97 |
ENST00000343846.3
ENST00000454695.2 ENST00000484758.2 |
SUSD4
|
sushi domain containing 4 |
chr17_+_12692774 | 11.86 |
ENST00000379672.5
ENST00000340825.3 |
ARHGAP44
|
Rho GTPase activating protein 44 |
chr17_+_73043301 | 11.81 |
ENST00000322444.6
|
KCTD2
|
potassium channel tetramerization domain containing 2 |
chr8_-_57359131 | 11.80 |
ENST00000518974.1
ENST00000523051.1 ENST00000518770.1 ENST00000451791.2 |
PENK
|
proenkephalin |
chr1_+_228353495 | 11.79 |
ENST00000366711.3
|
IBA57
|
IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) |
chr11_+_46368956 | 11.71 |
ENST00000543978.1
|
DGKZ
|
diacylglycerol kinase, zeta |
chr14_-_91526922 | 11.71 |
ENST00000418736.2
ENST00000261991.3 |
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
chr3_-_196065248 | 11.67 |
ENST00000446879.1
ENST00000273695.3 |
TM4SF19
|
transmembrane 4 L six family member 19 |
chr21_+_47878757 | 11.66 |
ENST00000400274.1
ENST00000427143.2 ENST00000318711.7 ENST00000457905.3 ENST00000466639.1 ENST00000435722.3 ENST00000417564.2 |
DIP2A
|
DIP2 disco-interacting protein 2 homolog A (Drosophila) |
chr3_-_149688655 | 11.64 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
chr6_-_167040731 | 11.54 |
ENST00000265678.4
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
chr8_-_144241664 | 11.45 |
ENST00000342752.4
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr19_+_42817527 | 11.43 |
ENST00000598766.1
|
TMEM145
|
transmembrane protein 145 |
chr10_-_48438974 | 11.41 |
ENST00000224605.2
|
GDF10
|
growth differentiation factor 10 |
chr6_-_39082922 | 11.39 |
ENST00000229903.4
|
SAYSD1
|
SAYSVFN motif domain containing 1 |
chr1_+_210502238 | 11.37 |
ENST00000545154.1
ENST00000537898.1 ENST00000391905.3 ENST00000545781.1 ENST00000261458.3 ENST00000308852.6 |
HHAT
|
hedgehog acyltransferase |
chr12_-_121734489 | 11.36 |
ENST00000412367.2
ENST00000402834.4 ENST00000404169.3 |
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta |
chr1_-_241520525 | 11.24 |
ENST00000366565.1
|
RGS7
|
regulator of G-protein signaling 7 |
chr10_-_104179682 | 11.23 |
ENST00000406432.1
|
PSD
|
pleckstrin and Sec7 domain containing |
chr11_+_113930291 | 11.22 |
ENST00000335953.4
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
chr7_-_150974494 | 11.21 |
ENST00000392811.2
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
chr11_+_108535849 | 11.20 |
ENST00000526794.1
|
DDX10
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 |
chr5_-_146258291 | 11.14 |
ENST00000394411.4
ENST00000453001.1 |
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta |
chr6_-_13487784 | 11.13 |
ENST00000379287.3
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
chr2_+_29338236 | 11.13 |
ENST00000320081.5
|
CLIP4
|
CAP-GLY domain containing linker protein family, member 4 |
chr12_+_53773944 | 11.08 |
ENST00000551969.1
ENST00000327443.4 |
SP1
|
Sp1 transcription factor |
chr15_+_99645277 | 11.08 |
ENST00000336292.6
ENST00000328642.7 |
SYNM
|
synemin, intermediate filament protein |
chr19_+_48281928 | 10.98 |
ENST00000593892.1
|
SEPW1
|
selenoprotein W, 1 |
chr1_-_15911510 | 10.97 |
ENST00000375826.3
|
AGMAT
|
agmatine ureohydrolase (agmatinase) |
chr2_-_28113965 | 10.93 |
ENST00000302188.3
|
RBKS
|
ribokinase |
chr15_-_77712477 | 10.91 |
ENST00000560626.2
|
PEAK1
|
pseudopodium-enriched atypical kinase 1 |
chrX_-_2418596 | 10.87 |
ENST00000381218.3
|
ZBED1
|
zinc finger, BED-type containing 1 |
chr2_+_113033164 | 10.87 |
ENST00000409871.1
ENST00000343936.4 |
ZC3H6
|
zinc finger CCCH-type containing 6 |
chr11_-_66336060 | 10.86 |
ENST00000310325.5
|
CTSF
|
cathepsin F |
chr3_+_49449636 | 10.80 |
ENST00000273590.3
|
TCTA
|
T-cell leukemia translocation altered |
chr6_-_52860171 | 10.64 |
ENST00000370963.4
|
GSTA4
|
glutathione S-transferase alpha 4 |
chr8_-_134309335 | 10.64 |
ENST00000522890.1
ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1
|
N-myc downstream regulated 1 |
chr3_-_179169330 | 10.63 |
ENST00000232564.3
|
GNB4
|
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
chr15_+_29131103 | 10.60 |
ENST00000558402.1
ENST00000558330.1 |
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
chr11_-_132813566 | 10.59 |
ENST00000331898.7
|
OPCML
|
opioid binding protein/cell adhesion molecule-like |
chr16_-_75498308 | 10.51 |
ENST00000569540.1
|
TMEM170A
|
transmembrane protein 170A |
chr7_-_158622210 | 10.47 |
ENST00000251527.5
|
ESYT2
|
extended synaptotagmin-like protein 2 |
chr16_+_66914264 | 10.47 |
ENST00000311765.2
ENST00000568869.1 ENST00000561704.1 ENST00000568398.1 ENST00000566776.1 |
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr8_+_85095553 | 10.44 |
ENST00000521268.1
|
RALYL
|
RALY RNA binding protein-like |
chr2_+_207308539 | 10.41 |
ENST00000374416.1
ENST00000374415.3 |
ADAM23
|
ADAM metallopeptidase domain 23 |
chr16_-_31085514 | 10.35 |
ENST00000300849.4
|
ZNF668
|
zinc finger protein 668 |
chr10_-_977564 | 10.29 |
ENST00000406525.2
|
LARP4B
|
La ribonucleoprotein domain family, member 4B |
chr5_+_65892174 | 10.20 |
ENST00000404260.3
ENST00000403625.2 ENST00000406374.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr22_+_29999647 | 10.17 |
ENST00000334961.7
ENST00000353887.4 |
NF2
|
neurofibromin 2 (merlin) |
chr19_+_48281946 | 10.16 |
ENST00000595615.1
|
SEPW1
|
selenoprotein W, 1 |
chr19_-_460996 | 10.10 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
chr9_-_115095851 | 10.09 |
ENST00000343327.2
|
PTBP3
|
polypyrimidine tract binding protein 3 |
chr7_-_108096765 | 10.00 |
ENST00000379024.4
ENST00000351718.4 |
NRCAM
|
neuronal cell adhesion molecule |
chrX_-_153363125 | 10.00 |
ENST00000407218.1
ENST00000453960.2 |
MECP2
|
methyl CpG binding protein 2 (Rett syndrome) |
chr11_-_64512273 | 9.99 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr13_+_113622757 | 9.96 |
ENST00000375604.2
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like |
chr9_-_13279563 | 9.96 |
ENST00000541718.1
|
MPDZ
|
multiple PDZ domain protein |
chr7_-_108096822 | 9.91 |
ENST00000379028.3
ENST00000413765.2 ENST00000379022.4 |
NRCAM
|
neuronal cell adhesion molecule |
chr2_-_97304009 | 9.89 |
ENST00000431828.1
ENST00000435669.1 ENST00000440133.1 ENST00000448075.1 |
KANSL3
|
KAT8 regulatory NSL complex subunit 3 |
chr6_-_31864977 | 9.89 |
ENST00000395728.3
ENST00000375528.4 |
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.4 | 67.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
22.1 | 66.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
17.6 | 52.8 | GO:2000374 | cadmium ion homeostasis(GO:0055073) negative regulation of hydrogen peroxide catabolic process(GO:2000296) regulation of oxygen metabolic process(GO:2000374) |
13.6 | 40.9 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
12.8 | 64.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
11.9 | 35.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
11.4 | 68.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
10.8 | 32.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
8.5 | 25.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
7.2 | 35.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
6.8 | 34.0 | GO:0030070 | insulin processing(GO:0030070) |
6.6 | 26.6 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
6.5 | 26.0 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
6.2 | 18.5 | GO:0032888 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
5.6 | 27.9 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
5.4 | 16.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
5.1 | 15.2 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
5.0 | 15.1 | GO:0044805 | late nucleophagy(GO:0044805) |
4.9 | 14.8 | GO:0007412 | axon target recognition(GO:0007412) |
4.9 | 19.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
4.5 | 13.6 | GO:0007518 | myoblast fate determination(GO:0007518) |
4.4 | 22.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
4.4 | 17.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
4.3 | 8.7 | GO:0010165 | response to X-ray(GO:0010165) |
4.3 | 55.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
4.2 | 16.9 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
4.2 | 12.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
4.0 | 20.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
4.0 | 55.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
4.0 | 11.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
3.8 | 26.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
3.8 | 7.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
3.6 | 14.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
3.4 | 10.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
3.4 | 24.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
3.4 | 20.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
3.3 | 9.9 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
3.2 | 12.9 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
3.2 | 9.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
3.1 | 145.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
3.0 | 14.8 | GO:0097338 | response to clozapine(GO:0097338) |
2.9 | 11.8 | GO:0051866 | general adaptation syndrome(GO:0051866) |
2.9 | 29.4 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
2.8 | 19.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
2.8 | 11.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
2.7 | 16.5 | GO:0060613 | fat pad development(GO:0060613) |
2.7 | 11.0 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
2.7 | 13.6 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
2.7 | 16.0 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
2.5 | 9.9 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
2.4 | 39.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
2.4 | 12.1 | GO:1990834 | response to odorant(GO:1990834) |
2.4 | 29.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.4 | 18.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.3 | 7.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
2.3 | 9.2 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
2.2 | 8.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
2.2 | 15.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
2.1 | 10.7 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
2.1 | 12.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
2.1 | 8.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
2.1 | 6.2 | GO:0051595 | response to methylglyoxal(GO:0051595) |
2.1 | 10.3 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
2.1 | 12.3 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
2.0 | 2.0 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
2.0 | 10.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.0 | 18.1 | GO:0035799 | ureter maturation(GO:0035799) |
2.0 | 29.9 | GO:0015671 | oxygen transport(GO:0015671) |
2.0 | 11.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.9 | 15.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.9 | 15.3 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
1.9 | 1.9 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.9 | 9.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.9 | 5.6 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.8 | 43.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.8 | 59.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.8 | 3.6 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
1.8 | 19.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.8 | 5.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
1.8 | 12.3 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
1.7 | 22.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.7 | 5.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.7 | 51.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.7 | 11.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.7 | 22.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.7 | 11.8 | GO:0070166 | enamel mineralization(GO:0070166) |
1.7 | 5.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
1.7 | 16.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
1.6 | 14.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.6 | 13.0 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
1.6 | 16.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
1.6 | 4.8 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
1.6 | 4.8 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
1.6 | 3.2 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
1.6 | 12.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.6 | 4.7 | GO:0003285 | septum secundum development(GO:0003285) |
1.6 | 6.2 | GO:0045740 | positive regulation of DNA replication(GO:0045740) positive regulation of telomerase activity(GO:0051973) |
1.6 | 17.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.6 | 9.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.5 | 7.7 | GO:0050893 | sensory processing(GO:0050893) |
1.5 | 4.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
1.5 | 89.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.5 | 10.5 | GO:0034770 | regulation of histone H3-K36 methylation(GO:0000414) histone H4-K20 methylation(GO:0034770) |
1.5 | 14.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.5 | 13.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.4 | 4.3 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
1.4 | 4.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.4 | 7.0 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
1.4 | 4.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
1.4 | 4.2 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
1.4 | 5.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
1.4 | 4.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.4 | 18.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.4 | 8.3 | GO:0032252 | secretory granule localization(GO:0032252) |
1.4 | 2.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.4 | 5.4 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
1.3 | 13.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
1.3 | 8.8 | GO:0009597 | detection of virus(GO:0009597) |
1.2 | 6.1 | GO:2000771 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) regulation of barbed-end actin filament capping(GO:2000812) positive regulation of barbed-end actin filament capping(GO:2000814) |
1.2 | 24.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.2 | 3.6 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
1.2 | 5.8 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.1 | 8.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.1 | 11.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.1 | 8.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
1.1 | 9.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
1.1 | 5.6 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
1.1 | 9.9 | GO:0048820 | hair follicle maturation(GO:0048820) |
1.1 | 3.3 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.1 | 1.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
1.0 | 8.1 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
1.0 | 4.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
1.0 | 3.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
1.0 | 20.1 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
1.0 | 15.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.0 | 5.9 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
1.0 | 11.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.0 | 4.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.0 | 23.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
1.0 | 4.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.0 | 21.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.9 | 5.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.9 | 5.7 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.9 | 4.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.9 | 2.8 | GO:0070781 | response to biotin(GO:0070781) |
0.9 | 6.4 | GO:0016051 | carbohydrate biosynthetic process(GO:0016051) |
0.9 | 26.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.9 | 17.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.9 | 8.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.9 | 6.3 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.9 | 3.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.9 | 15.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.9 | 4.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.9 | 5.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.9 | 4.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.9 | 8.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.9 | 15.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.8 | 22.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.8 | 4.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.8 | 5.7 | GO:0015824 | proline transport(GO:0015824) |
0.8 | 7.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.8 | 5.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.7 | 3.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.7 | 5.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.7 | 11.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.7 | 2.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.7 | 10.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.7 | 5.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 0.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.7 | 4.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.7 | 1.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.6 | 11.0 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.6 | 8.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.6 | 2.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.6 | 14.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.6 | 2.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.6 | 4.9 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.6 | 3.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.6 | 3.0 | GO:0086053 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.6 | 28.3 | GO:0001510 | RNA methylation(GO:0001510) |
0.6 | 7.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.6 | 39.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.6 | 2.4 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.6 | 8.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.6 | 2.9 | GO:1903059 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
0.6 | 2.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.6 | 4.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.6 | 10.8 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.6 | 13.6 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.6 | 4.5 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 0.5 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 9.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.5 | 10.4 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.5 | 2.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.5 | 4.3 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.5 | 11.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 6.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 6.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.5 | 3.1 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.5 | 1.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 3.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.5 | 2.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.5 | 4.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.5 | 3.0 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.5 | 5.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.5 | 10.9 | GO:0007628 | adult walking behavior(GO:0007628) |
0.5 | 13.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.5 | 4.4 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.5 | 1.9 | GO:0019086 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) late viral transcription(GO:0019086) |
0.5 | 15.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.5 | 3.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.5 | 1.9 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.5 | 3.8 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.5 | 4.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.5 | 6.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 1.4 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.5 | 1.4 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.5 | 16.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.4 | 4.9 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.4 | 34.5 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.4 | 3.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.4 | 16.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 2.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 3.1 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.4 | 2.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.4 | 8.9 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.4 | 3.8 | GO:0050713 | positive regulation of MHC class I biosynthetic process(GO:0045345) negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.4 | 6.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.4 | 1.2 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.4 | 2.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 15.2 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.4 | 14.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 | 0.8 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.4 | 8.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.4 | 3.5 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 14.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.4 | 9.8 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 1.9 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.4 | 11.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 1.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 18.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 3.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.4 | 11.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.4 | 27.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.4 | 9.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 7.7 | GO:0030183 | B cell differentiation(GO:0030183) |
0.4 | 0.7 | GO:0061010 | common bile duct development(GO:0061009) gall bladder development(GO:0061010) |
0.4 | 13.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.4 | 6.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.4 | 2.5 | GO:0035624 | receptor transactivation(GO:0035624) |
0.3 | 4.2 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.3 | 4.5 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.3 | 4.8 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.3 | 10.6 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.3 | 2.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 1.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 17.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.3 | 10.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.3 | 1.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 4.8 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.3 | 5.9 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 45.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.3 | 1.5 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.3 | 10.2 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.3 | 7.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.3 | 2.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 3.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 1.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.3 | 1.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 9.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 1.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 5.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 9.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 3.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.3 | 1.5 | GO:0008284 | positive regulation of cell proliferation(GO:0008284) |
0.2 | 6.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.2 | 3.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 1.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 29.6 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.2 | 0.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 1.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 6.4 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
0.2 | 0.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 2.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 2.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 3.6 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.2 | 1.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.8 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 8.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.2 | 4.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 8.0 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 13.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 3.7 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.2 | 1.9 | GO:0006325 | chromatin organization(GO:0006325) |
0.2 | 4.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 5.1 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.2 | 3.0 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.2 | 3.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 3.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 23.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.2 | 2.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.9 | GO:0015692 | lead ion transport(GO:0015692) |
0.2 | 4.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 5.0 | GO:0050776 | regulation of immune response(GO:0050776) |
0.2 | 0.5 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 4.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.2 | 6.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.2 | 0.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 3.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 6.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 0.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 20.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 0.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 5.8 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 6.8 | GO:0007417 | central nervous system development(GO:0007417) |
0.1 | 0.6 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.1 | 1.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 1.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 1.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 1.5 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.1 | 0.9 | GO:0051961 | negative regulation of nervous system development(GO:0051961) |
0.1 | 1.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.8 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 3.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 5.9 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 5.4 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 5.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 2.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 3.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 8.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 0.3 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
0.1 | 10.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 5.9 | GO:0030031 | cell projection assembly(GO:0030031) |
0.1 | 4.1 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.1 | 1.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 2.6 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 2.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 46.6 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.4 | GO:0090625 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 3.8 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 1.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 6.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.5 | GO:0042327 | positive regulation of phosphorylation(GO:0042327) |
0.1 | 2.8 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 6.2 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.1 | 2.3 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 5.0 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 1.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 1.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 1.6 | GO:0007399 | nervous system development(GO:0007399) |
0.0 | 1.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 1.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 4.4 | GO:0070268 | cornification(GO:0070268) |
0.0 | 1.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 2.3 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 3.1 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.6 | GO:0009205 | purine nucleoside triphosphate metabolic process(GO:0009144) purine ribonucleoside triphosphate metabolic process(GO:0009205) ATP metabolic process(GO:0046034) |
0.0 | 1.2 | GO:0006897 | endocytosis(GO:0006897) |
0.0 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 1.2 | GO:0099536 | synaptic signaling(GO:0099536) |
0.0 | 0.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.2 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.8 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.4 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 1.2 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.2 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.9 | 139.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
13.2 | 52.8 | GO:0097449 | astrocyte projection(GO:0097449) |
12.8 | 64.2 | GO:0045298 | tubulin complex(GO:0045298) |
9.5 | 38.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
8.9 | 79.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
7.5 | 29.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
6.5 | 32.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
6.2 | 18.5 | GO:0055028 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
4.8 | 33.6 | GO:0072487 | MSL complex(GO:0072487) |
4.3 | 13.0 | GO:0072534 | perineuronal net(GO:0072534) |
4.0 | 59.8 | GO:0005883 | neurofilament(GO:0005883) |
3.7 | 11.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
3.0 | 12.2 | GO:0070695 | FHF complex(GO:0070695) |
2.6 | 15.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
2.5 | 20.3 | GO:0045179 | apical cortex(GO:0045179) |
2.5 | 7.4 | GO:0016938 | kinesin I complex(GO:0016938) |
2.4 | 7.1 | GO:0043291 | RAVE complex(GO:0043291) |
2.3 | 27.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
2.3 | 16.2 | GO:0070852 | cell body fiber(GO:0070852) |
2.3 | 38.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.9 | 28.9 | GO:0000124 | SAGA complex(GO:0000124) |
1.8 | 5.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
1.8 | 10.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.7 | 8.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.6 | 146.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.6 | 14.2 | GO:0005638 | lamin filament(GO:0005638) |
1.5 | 19.9 | GO:0043194 | axon initial segment(GO:0043194) |
1.5 | 7.5 | GO:0000125 | PCAF complex(GO:0000125) |
1.4 | 5.4 | GO:0043293 | apoptosome(GO:0043293) |
1.3 | 2.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.3 | 4.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
1.3 | 32.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.3 | 18.3 | GO:0008091 | spectrin(GO:0008091) |
1.3 | 5.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.2 | 8.3 | GO:0097427 | microtubule bundle(GO:0097427) |
1.2 | 5.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.1 | 10.3 | GO:0005955 | calcineurin complex(GO:0005955) |
1.1 | 10.3 | GO:0072687 | meiotic spindle(GO:0072687) |
1.1 | 10.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 58.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.1 | 21.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.0 | 9.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.0 | 13.0 | GO:0043083 | synaptic cleft(GO:0043083) |
1.0 | 5.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.0 | 6.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.0 | 52.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.9 | 3.6 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.9 | 8.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.9 | 7.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.9 | 34.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 9.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 9.1 | GO:0031045 | dense core granule(GO:0031045) |
0.8 | 6.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.7 | 28.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.7 | 8.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.7 | 3.6 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.7 | 4.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 14.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.7 | 4.2 | GO:0042825 | TAP complex(GO:0042825) |
0.7 | 4.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.7 | 18.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.7 | 72.1 | GO:0005814 | centriole(GO:0005814) |
0.6 | 9.6 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.6 | 3.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 5.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.6 | 10.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 27.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.6 | 5.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 9.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 140.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.5 | 23.1 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 10.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 1.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.5 | 22.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.5 | 33.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 1.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 57.3 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 15.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 17.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.4 | 18.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 3.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.4 | 6.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 4.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 12.4 | GO:0005921 | gap junction(GO:0005921) |
0.4 | 1.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 7.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 2.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 6.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 4.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 13.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 47.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 8.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 28.4 | GO:0098793 | presynapse(GO:0098793) |
0.3 | 16.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 2.2 | GO:0043218 | internode region of axon(GO:0033269) compact myelin(GO:0043218) |
0.3 | 4.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 65.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.3 | 25.5 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.3 | 21.8 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.3 | 6.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 1.9 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 10.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 19.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 3.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 12.9 | GO:0044456 | synapse part(GO:0044456) |
0.2 | 4.2 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 1.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 2.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 3.8 | GO:0030133 | transport vesicle(GO:0030133) |
0.2 | 3.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 2.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 6.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 4.4 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.9 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 7.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 1.6 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.2 | 88.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 5.4 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 10.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 6.3 | GO:0005844 | polysome(GO:0005844) |
0.1 | 9.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 1.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 5.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 14.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 6.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 5.1 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 3.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 6.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 6.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 2.7 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 33.7 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 1.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 10.4 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 2.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 5.7 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 4.5 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 4.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 3.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 31.6 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 3.0 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 2.9 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 4.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 2.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 2.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 5.4 | GO:0005929 | cilium(GO:0005929) |
0.0 | 2.2 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.7 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.1 | 64.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
13.0 | 38.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
11.6 | 139.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
8.3 | 66.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
5.9 | 41.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
5.1 | 15.2 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
4.6 | 59.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
4.3 | 17.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
4.2 | 12.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
4.1 | 53.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
4.1 | 12.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
4.0 | 16.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
3.7 | 14.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
3.7 | 25.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
3.6 | 10.7 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
3.5 | 10.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
3.3 | 85.1 | GO:0031489 | myosin V binding(GO:0031489) |
3.2 | 9.7 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
3.1 | 58.3 | GO:0048156 | tau protein binding(GO:0048156) |
2.7 | 10.9 | GO:0004803 | transposase activity(GO:0004803) |
2.7 | 29.6 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
2.7 | 13.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
2.6 | 15.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.6 | 13.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
2.4 | 14.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
2.4 | 9.5 | GO:0016972 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
2.4 | 18.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
2.3 | 9.3 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
2.3 | 29.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
2.1 | 25.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
2.1 | 8.4 | GO:0035939 | microsatellite binding(GO:0035939) |
2.0 | 6.0 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
2.0 | 11.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.9 | 9.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
1.8 | 43.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.8 | 14.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.8 | 19.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.8 | 28.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.7 | 7.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.7 | 10.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.7 | 11.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.7 | 6.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.7 | 28.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.6 | 19.4 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.6 | 4.8 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
1.6 | 9.5 | GO:0039552 | RIG-I binding(GO:0039552) |
1.5 | 20.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.5 | 16.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.5 | 19.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.5 | 4.5 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
1.5 | 18.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.5 | 4.4 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
1.5 | 26.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.5 | 14.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.4 | 4.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
1.4 | 4.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.3 | 6.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
1.3 | 32.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.3 | 6.5 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.3 | 7.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.3 | 5.1 | GO:0008940 | nitrate reductase activity(GO:0008940) |
1.3 | 5.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.2 | 9.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
1.2 | 4.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
1.2 | 18.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.2 | 15.2 | GO:0031005 | filamin binding(GO:0031005) |
1.1 | 6.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.1 | 44.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.1 | 5.6 | GO:0052845 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
1.1 | 8.5 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
1.0 | 4.2 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
1.0 | 45.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.0 | 26.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.0 | 3.1 | GO:0000995 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) transcription factor activity, core RNA polymerase III binding(GO:0000995) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
1.0 | 3.0 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
1.0 | 20.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.0 | 3.0 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.9 | 5.7 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.9 | 8.4 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.9 | 24.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.9 | 4.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.9 | 5.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.9 | 10.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.9 | 4.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.9 | 9.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 2.5 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.8 | 2.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.8 | 3.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.8 | 30.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.8 | 10.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.8 | 2.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.8 | 11.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.8 | 13.1 | GO:0005112 | Notch binding(GO:0005112) |
0.8 | 1.5 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.8 | 4.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.8 | 13.0 | GO:0070888 | E-box binding(GO:0070888) |
0.8 | 12.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 8.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 3.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.7 | 5.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.7 | 5.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 7.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 25.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.7 | 11.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 4.9 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.7 | 25.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.7 | 1.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.7 | 2.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.7 | 4.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.7 | 10.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 4.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 0.7 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.6 | 13.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.6 | 11.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 4.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 8.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 28.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 1.9 | GO:0032093 | SAM domain binding(GO:0032093) |
0.6 | 34.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.6 | 11.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.6 | 19.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.6 | 3.0 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.6 | 23.9 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.6 | 40.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 9.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 13.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 7.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 32.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.5 | 27.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.5 | 13.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 3.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 7.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.5 | 5.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.5 | 2.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 1.9 | GO:0005534 | galactose binding(GO:0005534) |
0.5 | 6.6 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.5 | 2.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 1.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.5 | 2.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.5 | 22.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 3.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.5 | 1.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 6.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.4 | 7.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 8.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 4.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.4 | 5.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 11.4 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.4 | 8.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 5.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 2.9 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 3.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 10.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 65.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 15.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 5.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 4.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 20.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 3.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 8.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 8.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 5.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 2.8 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 5.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 3.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 9.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 31.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.3 | 4.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 2.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 0.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 11.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 9.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 1.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 2.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 15.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 12.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 5.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 2.8 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 6.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 9.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.3 | 1.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 6.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 1.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 28.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 6.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 3.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 11.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 35.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 4.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.9 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.2 | 15.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 3.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 2.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.6 | GO:0070984 | SET domain binding(GO:0070984) |
0.2 | 5.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 2.0 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 10.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 1.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 5.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 4.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 3.8 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 4.8 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 5.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 40.2 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.2 | 0.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.2 | 9.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 18.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 8.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 0.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.5 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 6.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 5.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 11.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 8.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 1.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 4.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 6.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 4.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 5.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 4.8 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 2.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 2.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 7.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 7.2 | GO:0016247 | channel regulator activity(GO:0016247) |
0.1 | 4.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 4.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 2.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 5.8 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 3.5 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 8.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 3.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.7 | GO:0045499 | ErbB-3 class receptor binding(GO:0043125) chemorepellent activity(GO:0045499) |
0.1 | 0.5 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 4.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 13.9 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 2.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 3.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 2.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 10.6 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 2.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 3.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 13.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 14.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 1.1 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 1.9 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.4 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 49.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.8 | 101.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.7 | 41.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.7 | 85.5 | PID RAS PATHWAY | Regulation of Ras family activation |
1.6 | 26.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.6 | 4.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.4 | 5.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.9 | 56.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.8 | 39.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.7 | 44.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.7 | 26.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.7 | 16.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 18.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.6 | 2.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 34.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 57.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 11.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 16.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.5 | 24.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 14.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 11.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 19.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 11.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 5.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 11.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 2.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 9.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 5.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 16.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 11.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 1.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 5.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 58.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 8.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 9.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 9.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 3.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 15.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 0.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 5.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 6.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 47.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 12.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 5.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 4.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 3.2 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 2.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 3.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 5.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 1.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 2.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.5 | 180.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.7 | 32.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
2.3 | 77.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.3 | 29.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.9 | 29.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.8 | 3.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.7 | 10.3 | REACTOME SIGNALING BY GPCR | Genes involved in Signaling by GPCR |
1.7 | 55.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.5 | 4.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.3 | 48.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.2 | 55.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.2 | 19.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.2 | 30.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.1 | 22.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.1 | 13.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.0 | 26.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.9 | 15.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.9 | 6.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.8 | 14.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.8 | 23.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.7 | 15.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 9.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.7 | 12.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.7 | 14.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.6 | 14.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.6 | 17.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 18.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.5 | 8.7 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.5 | 4.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.5 | 14.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.5 | 23.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 9.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.5 | 1.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.5 | 7.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.4 | 8.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 11.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 13.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 7.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 8.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 7.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 9.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 3.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.4 | 16.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.4 | 5.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.4 | 4.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 12.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 12.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 9.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 56.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 7.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 12.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 4.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 5.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 3.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 5.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 5.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 3.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 7.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 5.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 4.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 5.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 4.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 4.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 4.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 10.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 5.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 33.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 1.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 3.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 2.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 5.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 3.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 5.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 3.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 5.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 5.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 5.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 1.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 3.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.9 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 0.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 1.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 5.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 6.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 5.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 11.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 5.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.8 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.7 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |